Spain· ES:54213
RIFINAH 300 MG/150 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA
A medicinal product containing rifampicina + isoniazida, registered in Spain by Sanofi Aventis S.A..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- rifampicina + isoniazida
- Manufacturer
- Sanofi Aventis S.A.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo81797360EUR 23.84
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rifampicina + isoniazida in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomRifamazid 150mg/100mg capsulesImported (Poland)
- NorwayRifinahsanofi-aventis (2)
- SwitzerlandRifinah, comprimés enrobésSanofi-Aventis (Suisse) SA
- IrelandRifinah 150/100 mg Film- Coated TabletsSanofi-Aventis Ireland Limited T/A SANOFI
- NetherlandsRifinah 300 mg/150 mg, filmomhulde tabletSanofi B.V.
- PolandRifamazidTarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- SwedenRimactazid 150 mg/75 mg Filmdragerad tablettSandoz A/S
- FranceRIFINAH 300 mg/150 mg, comprimé enrobéSANOFI WINTHROP INDUSTRIE
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Rifoldin Mit Inh
- Cyprus · Rifamazid
- Denmark · Rimactazid
- France · Rifinah
- United Kingdom (Northern Ireland) · Rifinah
- Greece · Rifinah
- Hungary · Rifazid
- Ireland · Rifinah
- Italy · Rifinah
- Lithuania · Rifamazid
- Netherlands · Rifinah
- Norway · Rimactazid
- Poland · Rifamazid
- Portugal · Rifinah
- Romania · Sinerdol Iso
- Sweden · Rimactazid
- Slovenia · Rifinah
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/01d131dd-80f3-458c-8012-e90304fbfd9c GET /v1/drugs/01d131dd-80f3-458c-8012-e90304fbfd9c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración",
"estado": "{\"aut\":273448800000}",
"nregistro": "54213",
"substance": "rifampicina + isoniazida"
}See everything about rifampicina + isoniazida.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.